Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 20, 2009, 12:49PM ET - U.S. Markets Closed. Dow Up 0.20% Nasdaq Up 1.45%
Rosetta Genomics, Ltd. (ROSG)On Dec 18: 1.94  Down 0.15 (7.17%)  
MORE ON ROSG
Quotes
Charts
News & Info
Company
HereCompetitors
Analyst Coverage
Ownership
Financials

CompetitorsGet Competitors for:
DIRECT COMPETITOR COMPARISON 
ROSGALNYISISMRKIndustry
Market Cap:27.50M730.93M977.90M78.88B47.35M
Employ­ees:N/A17530055,20056
Qtrly Rev Growth (yoy):N/A-5.80%-9.10%1.80%18.90%
Revenue (ttm):1.54M98.31M118.99M23.37B12.73M
Gross Margin (ttm):30.03%-2.31%-1.31%76.36%51.15%
EBITDA (ttm):-13.56M-41.20M-16.09M7.81B-1.76M
Oper Margins (ttm):-907.07%-48.68%-19.54%26.63%-19.80%
Net Income (ttm):-9.10M-49.19M-11.27M8.05BN/A
EPS (ttm):-0.873-1.1851.6173.808N/A
P/E (ttm):N/AN/A6.159.8223.95
PEG (5 yr expected):N/AN/A0.222.261.38
P/S (ttm):19.217.088.233.363.47
ALNY = Alnylam Pharmaceuticals, Inc.
ISIS = Isis Pharmaceuticals, Inc.
MRK = Merck & Co. Inc.
Industry = Diagnostic Substances

BIOTECHNOLOGY COMPANIES RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN55.802.24%56.48B12.17
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB50.071.25%14.48B16.76
Genzyme Corp.GENZ48.781.20%12.95B27.81
Merck Serono S.A.Private - View Profile
Chiron CorporationPrivate - View Profile
Gilead Sciences Inc.GILD42.83-0.86%38.54B16.56
MedImmune, Inc.Private - View Profile
Life Technologies CorporationLIFE51.280.81%9.15B1046.53
Teva Pharmaceutical Industries LimitedTEVA52.910.84%46.61B48.41
View Diagnostic Substances Industry Center

GENERIC DRUGMAKERS RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
Sandoz International GmbHPrivate - View Profile
Watson Pharmaceuticals Inc.WPI38.090.42%4.04B19.63
King Pharmaceuticals Inc.KG11.891.80%2.95BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL18.25-0.92%5.58B111.96
Pfizer Inc.PFE18.300.44%147.67B15.20
Johnson & JohnsonJNJ64.37-0.16%177.60B14.06
GlaxoSmithKline plcGSK41.80-0.36%105.96B13.53
Sanofi-AventisSNY39.111.90%102.12BN/A
Novartis AGNVS54.210.58%123.12B16.23
View Diagnostic Substances Industry Center

DRUGMAKERS RANKED BY SALES 
CompanySymbolPriceChangeMarket CapP/E
RHHBY.PK41.950.70%N/AN/A
AstraZeneca plcAZN45.54-0.11%66.03B9.14
Abbott LaboratoriesABT53.34-0.45%82.50B14.45
Bristol-Myers Squibb Co.BMY25.780.04%51.07B13.34
View Diagnostic Substances Industry Center

NEWS ON DIRECT COMPETITORS 
MRK2009: The Year Pharma Learned to Love Itself
Fri, Dec 18 - at Motley Fool
MRKBuy a Company, Get the Plant for Free
Fri, Dec 18 - at Motley Fool
MRKThe Only Asset Worth Owning Today
Fri, Dec 18 - at Motley Fool
MRKABT Seeks Simcor Label Expansion
Fri, Dec 18 - Zacks.com
MRKAnadys Drug Meets Key Study Goals
Fri, Dec 18 - Zacks.com
MRKUPDATE - European experts recommend Amgen, Glaxo bone drug
Fri, Dec 18 - at Reuters
MRKAriad rounds out phase 3 cancer study
Fri, Dec 18 - at bizjournals.com
ISISThese 5 Underdogs Are No Dogs
Thu, Dec 17 - at Motley Fool
ALNYRegulus Therapeutics Receives Exclusive License for Intellectual Property on Immuno-inflammatory microRNAs from the California Institute of Technology
Thu, Dec 17 - Business Wire
ALNYIsis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics
Tue, Dec 15 - Business Wire
ISISMaking and Breaking Biotech Deals
Mon, Dec 14 - at Seeking Alpha
ISIS4-Star Stocks Poised to Pop: Isis Pharmaceuticals
Fri, Dec 11 - at Motley Fool
ISIS3 Stocks Hitting Low Notes
Wed, Dec 9 - at Motley Fool
ALNYRegulus Therapeutics Inc. presents: "MicroRNA: The Year in Review and a Look Ahead"
Wed, Dec 9 - Business Wire
ALNYAlnylam to Webcast Presentation at Piper Jaffray 21st Annual Health Care Conference
Tue, Nov 24 - Business Wire
ALNYAlnylam Pharma downgraded by Roth Capital
Tue, Nov 24 - Briefing.com
All Headlines for these symbols...

Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.


Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Competitors for Another Symbol: Symbol Lookup
Stock ScreenerSector Analysis